This is an aggregated industry headline. Read the full story at FierceBiotech →
Australian biopharma Clinuvel to shed up to 20% of workforce in move to US
Australian biopharma Clinuvel Pharmaceuticals is moving its headquarters to the U.S.- but up to a fifth of the company's workforce won't be staying for the trans-Pacific pivot.
By FierceBiotech
· Jul 23, 2026
· via FierceBiotech
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
The former quarterback spoke with Fierce Pharma Marketing on teaming up with ARS, his journey with food allerg…
The WeekBriefing
FDA clears GSK’s Jideytro, the company’s first lung cancer drug, marking a swift return on its $10.6B Nuvalent…
The WeekSTAT News ↗
Mirroring the bipartisan bill introduced in the House, the measure would require a study from the GAO on the s…